tradingkey.logo

Mirion Technologies Inc

MIR

20.310USD

+0.450+2.27%
Market hours ETQuotes delayed by 15 min
380.81MMarket Cap
LossP/E TTM

Mirion Technologies Inc

20.310

+0.450+2.27%
More Details of Mirion Technologies Inc Company
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets. The Company's segments include Medical and Technologies. The Medical segment includes products and services for radiation therapy and personal dosimetry. This segment's offerings include solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy; solutions for monitoring the total amount of radiation medical staff members are exposed to over time, and products for nuclear medicine in radiation measurement, shielding, product handling, medical imaging furniture and rehabilitation. The Technologies segment includes products and services for defense, nuclear energy, laboratories and research and other industrial markets. This segment's offerings include reactor safety and control systems, and radiological search, measurement and analysis systems.
Company Info
Ticker SymbolMIR
Company nameMirion Technologies Inc
IPO dateJun 29, 2020
CEOMr. Thomas D. Logan
Number of employees2860
Security typeOrdinary Share
Fiscal year-endJun 29
Address1218 Menlo Drive
CityATLANTA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code30318
Phone17704322744
Websitehttps://www.mirion.com/
Ticker SymbolMIR
IPO dateJun 29, 2020
CEOMr. Thomas D. Logan
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+0.17%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
768.63K
--
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
146.00K
+27.26%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
76.18K
+11.70%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
74.22K
+1.40%
Ms. Emmanuelle Lee
Ms. Emmanuelle Lee
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
55.43K
-10.52%
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Director
Independent Director
50.04K
+18.96%
Mrs. Alison Ulrich
Mrs. Alison Ulrich
Chief Human Resources Officer
Chief Human Resources Officer
16.28K
-14.94%
Ms. Jody A. Markopoulos
Ms. Jody A. Markopoulos
Independent Director
Independent Director
--
--
Mr. Eric Linn
Mr. Eric Linn
Investor Relations
Investor Relations
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Lawrence D. (Larry) Kingsley
Mr. Lawrence D. (Larry) Kingsley
Independent Director
Independent Director
4.76M
+0.17%
Mr. Brian Schopfer
Mr. Brian Schopfer
Chief Financial Officer
Chief Financial Officer
768.63K
--
Mr. Loic Eloy
Mr. Loic Eloy
Group President - Nuclear and Safety
Group President - Nuclear and Safety
146.00K
+27.26%
Mr. Kenneth C. Bockhorst
Mr. Kenneth C. Bockhorst
Lead Independent Director
Lead Independent Director
76.18K
+11.70%
Mr. John W. Kuo, J.D.
Mr. John W. Kuo, J.D.
Independent Director
Independent Director
74.22K
+1.40%
Ms. Emmanuelle Lee
Ms. Emmanuelle Lee
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
Chief Legal Officer, Chief Compliance Office, Deputy General Counsel
55.43K
-10.52%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Nuclear
84.10M
41.63%
Cancer care
51.00M
25.25%
Labs and research
26.80M
13.27%
Nuclear and safety-Other
22.50M
11.14%
Medical-Other
17.60M
8.71%
By RegionUSD
Name
Revenue
Proportion
Northern America
130.70M
64.70%
Europe
65.50M
32.43%
Asia Pacific
5.80M
2.87%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Nuclear
84.10M
41.63%
Cancer care
51.00M
25.25%
Labs and research
26.80M
13.27%
Nuclear and safety-Other
22.50M
11.14%
Medical-Other
17.60M
8.71%
Shareholding Stats
Updated: Tue, Jul 29
Updated: Tue, Jul 29
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.35%
T. Rowe Price Investment Management, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
6.41%
Janus Henderson Investors
3.83%
Maverick Capital, Ltd.
3.59%
Other
66.59%
Shareholders
Shareholders
Proportion
The Vanguard Group, Inc.
10.35%
T. Rowe Price Investment Management, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
6.41%
Janus Henderson Investors
3.83%
Maverick Capital, Ltd.
3.59%
Other
66.59%
Shareholder Types
Shareholders
Proportion
Investment Advisor
38.19%
Investment Advisor/Hedge Fund
30.30%
Hedge Fund
13.43%
Individual Investor
4.46%
Family Office
3.17%
Research Firm
1.53%
Bank and Trust
0.41%
Pension Fund
0.32%
Sovereign Wealth Fund
0.08%
Other
8.12%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
470
200.33M
88.82%
-14.93M
2025Q1
461
196.77M
87.24%
-13.76M
2024Q4
413
201.38M
89.23%
-34.17M
2024Q3
364
208.86M
92.88%
-24.70M
2024Q2
347
200.91M
91.31%
-22.95M
2024Q1
340
192.50M
88.03%
-24.17M
2023Q4
330
191.09M
87.68%
-28.19M
2023Q3
353
191.03M
87.66%
-36.72M
2023Q2
372
194.38M
89.64%
-28.89M
2023Q1
376
190.72M
88.05%
-23.00M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
The Vanguard Group, Inc.
23.21M
10.29%
-651.75K
-2.73%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
20.71M
9.18%
+322.24K
+1.58%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
14.39M
6.38%
-56.89K
-0.39%
Mar 31, 2025
Janus Henderson Investors
8.59M
3.81%
+257.17K
+3.09%
Mar 31, 2025
Maverick Capital, Ltd.
8.06M
3.57%
+1.88M
+30.41%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
7.36M
3.26%
+178.26K
+2.48%
Mar 31, 2025
Omega Advisors, Inc.
7.03M
3.11%
--
--
Mar 31, 2025
Brown Advisory
5.56M
2.47%
+1.75M
+45.87%
Mar 31, 2025
State Street Global Advisors (US)
5.14M
2.28%
-61.52K
-1.18%
Mar 31, 2025
Kingsley (Lawrence D)
4.76M
2.11%
+7.98K
+0.17%
May 23, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
Gabelli Love Our Planet & People ETF
5.15%
Strategas Macro Momentum ETF
1.77%
Invesco Dorsey Wright Technology Momentum ETF
1.64%
SPDR S&P Kensho Future Security ETF
1.15%
Range Nuclear Renaissance Index ETF
1.04%
Even Herd Long Short ETF
0.6%
First Trust Small Cap Growth AlphaDEX Fund
0.48%
First Trust Multi-Manager Small Cap Opportunities ETF
0.42%
Invesco Dorsey Wright SmallCap Momentum ETF
0.38%
SPDR S&P Kensho New Economies Composite ETF
0.36%
View more
Gabelli Love Our Planet & People ETF
Proportion5.15%
Strategas Macro Momentum ETF
Proportion1.77%
Invesco Dorsey Wright Technology Momentum ETF
Proportion1.64%
SPDR S&P Kensho Future Security ETF
Proportion1.15%
Range Nuclear Renaissance Index ETF
Proportion1.04%
Even Herd Long Short ETF
Proportion0.6%
First Trust Small Cap Growth AlphaDEX Fund
Proportion0.48%
First Trust Multi-Manager Small Cap Opportunities ETF
Proportion0.42%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.38%
SPDR S&P Kensho New Economies Composite ETF
Proportion0.36%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI